Founded in 2003 and with more than 3,500 references in 62 countries across the world, Dohmeyer is well placed to share its observations of the cryogenic processing market from an equipment design and supply perspective.
The company has been incredibly busy for the past 24 months. The global coronavirus (Covid-19) pandemic has had a marked effect on the industry and delayed investment decisions within its traditional customer base. Dohmeyer, however, has been approached and become the chosen partner of many pharmaceutical companies for its experience and expertise in designing equipment for new and modified applications.
Recent events concerning the unprecedented global effect of Covid-19 has accelerated work on the controlled rate freezing and storage of vaccines. Dohmeyer has been at the vanguard of this research and development, with its own highly skilled engineering team they have been able to produce new designs based on existing machinery and put these into manufacture and have them installed and operational within the expectations of their customers, at this exceptional time.
... to continue reading you must be subscribed
